 |
| |
Summary of Symptoms |
|
Asthma
|
Yaz
may cause symptoms that are related to asthma
|
|
Cough due to asthma
|
Yaz
may cause symptoms that are related to cough due to asthma
|
|
Heavy breathing
|
Yaz
may cause symptoms that are related to heavy breathing
|
|
Insomnia and other sleep problems
|
Yaz
may cause insomnia and other sleep problems.
|
| |
|
|
|
|
|
Asthma
|
Yaz (drospirenone-ethinyl estradiol)
may cause the following symptoms that are related to asthma:- Angioedema.
- Bronchitis
- Chronic obstructive pulmonary disease
- Infection of the upper respiratory tract
- Pulmonary veno-occlusive disease
Hide SOURCE +
Note: Original Source for Medical Professionals
A case of fatal pulmonary occlusive disease has been associated with oral contraceptive therapy. Hypersensitivity side effects have included anaphylactic/anaphylactoid reactions, including urticaria, angioedema, and severe reactions with respiratory and circulatory symptoms. Respiratory side effects have included upper respiratory infection, sinusitis, pharyngitis, sore throat, rhinitis, and bronchitis in postmarketing reports.
REFERENCE +
- Long-term health risks and benefits of oral contraceptive use. Peterson HB, Lee NC Obstet Gynecol Clin North Am 1990;17:775-88.
- Benefits and risks of oral contraceptive use. Williams RS Postgrad Med 1992;92:155-7.
- Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D Obstet Gynecol 1994;83:679-85.
- Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Colditz GA Ann Intern Med 1994;120:821-6.
- The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA Am J Obstet Gynecol 1992;166:1950-4.
- Oral contraceptives: a reassessment. Derman R Obstet Gynecol Surv 1989;44:662-8.
- Product Information. Yasmin (drospirenone-ethinyl estradiol) Anonymous Berlex Laboratories, Richmond, CA. PROD;
- Oral contraception: risks and benefits. Steinberg WM Adv Contracept 1989;5:219-28.
- Choosing the best oral contraceptive. Stubblefield PG Clin Obstet Gynecol 1989;32:316-28.
- Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases. Beaumont V, Lemort N, Beaumont JL Eur Heart J 1991;12:1219-24.
- Contraception. Mishell DR N Engl J Med 1989;320:777-85.
- Benefits and risk of oral contraceptives. A reassessment. Burkman RT Jr J Reprod Med 1991;36:217-8.
- Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives. Julkunen H, Kaaja R, Jouhikainen T, Teppo AM, Friman C Br J Rheumatol 1991;30:471-2.
|
|
| |
|
|
|
| |
| |
|
|
|
|
|
Cough due to asthma
|
Yaz (drospirenone-ethinyl estradiol)
may cause the following symptoms that are related to cough due to asthma:- Angioedema.
- Chronic obstructive pulmonary disease
- Flu or cold-like symptoms
Hide SOURCE +
Note: Original Source for Medical Professionals
A case of fatal pulmonary occlusive disease has been associated with oral contraceptive therapy. Hypersensitivity side effects have included anaphylactic/anaphylactoid reactions, including urticaria, angioedema, and severe reactions with respiratory and circulatory symptoms. General side effects have included exacerbations of systemic lupus erythematosus, porphyria, chorea, and a possible diminution in lactation when given immediately postpartum. Flu syndrome, tooth disorder, infection, accidental injury, and weight gain have been reported in postmarketing experience.
REFERENCE +
- Long-term health risks and benefits of oral contraceptive use. Peterson HB, Lee NC Obstet Gynecol Clin North Am 1990;17:775-88.
- Benefits and risks of oral contraceptive use. Williams RS Postgrad Med 1992;92:155-7.
- Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D Obstet Gynecol 1994;83:679-85.
- Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Colditz GA Ann Intern Med 1994;120:821-6.
- The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA Am J Obstet Gynecol 1992;166:1950-4.
- Oral contraceptives: a reassessment. Derman R Obstet Gynecol Surv 1989;44:662-8.
- Product Information. Yasmin (drospirenone-ethinyl estradiol) Anonymous Berlex Laboratories, Richmond, CA. PROD;
- Oral contraception: risks and benefits. Steinberg WM Adv Contracept 1989;5:219-28.
- Choosing the best oral contraceptive. Stubblefield PG Clin Obstet Gynecol 1989;32:316-28.
- Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases. Beaumont V, Lemort N, Beaumont JL Eur Heart J 1991;12:1219-24.
- Contraception. Mishell DR N Engl J Med 1989;320:777-85.
- Benefits and risk of oral contraceptives. A reassessment. Burkman RT Jr J Reprod Med 1991;36:217-8.
- Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives. Julkunen H, Kaaja R, Jouhikainen T, Teppo AM, Friman C Br J Rheumatol 1991;30:471-2.
|
|
| |
|
|
|
| |
| |
|
|
|
|
|
Heavy breathing
|
Yaz (drospirenone-ethinyl estradiol)
may cause the following symptoms that are related to heavy breathing:- Angioedema.
- Chronic obstructive pulmonary disease
Hide SOURCE +
Note: Original Source for Medical Professionals
A case of fatal pulmonary occlusive disease has been associated with oral contraceptive therapy. Hypersensitivity side effects have included anaphylactic/anaphylactoid reactions, including urticaria, angioedema, and severe reactions with respiratory and circulatory symptoms.
REFERENCE +
- Long-term health risks and benefits of oral contraceptive use. Peterson HB, Lee NC Obstet Gynecol Clin North Am 1990;17:775-88.
- Benefits and risks of oral contraceptive use. Williams RS Postgrad Med 1992;92:155-7.
- Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D Obstet Gynecol 1994;83:679-85.
- Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Colditz GA Ann Intern Med 1994;120:821-6.
- The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA Am J Obstet Gynecol 1992;166:1950-4.
- Oral contraceptives: a reassessment. Derman R Obstet Gynecol Surv 1989;44:662-8.
- Product Information. Yasmin (drospirenone-ethinyl estradiol) Anonymous Berlex Laboratories, Richmond, CA. PROD;
- Oral contraception: risks and benefits. Steinberg WM Adv Contracept 1989;5:219-28.
- Choosing the best oral contraceptive. Stubblefield PG Clin Obstet Gynecol 1989;32:316-28.
- Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases. Beaumont V, Lemort N, Beaumont JL Eur Heart J 1991;12:1219-24.
- Contraception. Mishell DR N Engl J Med 1989;320:777-85.
- Benefits and risk of oral contraceptives. A reassessment. Burkman RT Jr J Reprod Med 1991;36:217-8.
- Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives. Julkunen H, Kaaja R, Jouhikainen T, Teppo AM, Friman C Br J Rheumatol 1991;30:471-2.
|
|
| |
|
|
|
| |
| |
|
|
|
|
|
Insomnia and other sleep problems
|
Yaz (drospirenone-ethinyl estradiol)
may cause insomnia and other sleep problems.This drug may also cause the following symptoms that are related to insomnia and other sleep problems:
Hide SOURCE +
Note: Original Source for Medical Professionals
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have any of these serious side effects:
sudden numbness or weakness, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
a change in the pattern or severity of migraine headaches;
stomach pain, loss of appetite, jaundice ( yellowing of the skin or eyes);
a breast lump; or
symptoms of depression ( sleep problems, weakness, mood changes).
Less serious side effects may include:
breast pain, tenderness, or swelling;
freckles or darkening of facial skin, increased hair growth, or loss of scalp hair;
changes in weight or appetite, swelling of your hands or feet;
problems with contact lenses;
vaginal itching or discharge; or
changes in your menstrual periods.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.
|
|
| |
|
|
|
| |
|
|
|
|